Asia Pacific Drug Delivery Systems Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
to 2027 - Regional Analysis and Forecasts by Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others), and Country

No. of Pages: 261    |    Report Code: TIPRE00007130    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Drug Delivery Systems Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Drug Delivery Systems Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Drug Delivery Systems Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing demand for targeted drug delivery systems
  • 5.1.2 Advancements in drug delivery technologies for chronic diseases
5.2 Market Opportunities
  • 5.2.1 Advancements in drug delivery technologies creating opportunities for targeted and efficient drug delivery systems
  • 5.2.2 Rising demand for personalized drug delivery driving market growth
5.3 Future Trends
  • 5.3.1 Demand for non-invasive drug delivery systems
  • 5.3.2 Advancements in controlled-release and personalized drug delivery solutions
5.4 Impact of Drivers and Restraints

6. Asia Pacific Drug Delivery Systems Market Regional Analysis

6.1 Asia Pacific Drug Delivery Systems Market Overview
6.2 Asia Pacific Drug Delivery Systems Market Revenue 2016-2027 (US$ Million)
6.3 Asia Pacific Drug Delivery Systems Market Forecast Analysis

7. Asia Pacific Drug Delivery Systems Market Analysis – by Route of Administration

7.1 Transmucosal
  • 7.1.1 Overview
  • 7.1.2 Transmucosal: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Oral
  • 7.2.1 Overview
  • 7.2.2 Oral: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Injectable
  • 7.3.1 Overview
  • 7.3.2 Injectable: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Topical
  • 7.4.1 Overview
  • 7.4.2 Topical: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Implantable
  • 7.5.1 Overview
  • 7.5.2 Implantable: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Ocular
  • 7.6.1 Overview
  • 7.6.2 Ocular: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Drug Delivery Systems Market Analysis – by Distribution Channel

8.1 Hospital Pharmacies
  • 8.1.1 Overview
  • 8.1.2 Hospital Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Retail Pharmacies
  • 8.2.1 Overview
  • 8.2.2 Retail Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Online Pharmacies
  • 8.3.1 Overview
  • 8.3.2 Online Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

9. Asia Pacific Drug Delivery Systems Market Analysis – by Application

9.1 Home Care Settings
  • 9.1.1 Overview
  • 9.1.2 Online Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Hospitals & Clinics
  • 9.2.1 Overview
  • 9.2.2 Online Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

10. Asia Pacific Drug Delivery Systems Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Drug Delivery Systems Market Breakdown, by Key Country, 2019 and 2027 (%)
  • 10.1.1.1 Asia Pacific Drug Delivery Systems Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Drug Delivery Systems Market Breakdown, by Route of Administration
    • 10.1.1.1.2 China: Asia Pacific Drug Delivery Systems Market Breakdown, by Distribution Channel
    • 10.1.1.1.3 China: Asia Pacific Drug Delivery Systems Market Breakdown, by Application
  • 10.1.1.2 India: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Drug Delivery Systems Market Breakdown, by Route of Administration
    • 10.1.1.2.2 India: Asia Pacific Drug Delivery Systems Market Breakdown, by Distribution Channel
    • 10.1.1.2.3 India: Asia Pacific Drug Delivery Systems Market Breakdown, by Application
  • 10.1.1.3 Japan: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Drug Delivery Systems Market Breakdown, by Route of Administration
    • 10.1.1.3.2 Japan: Asia Pacific Drug Delivery Systems Market Breakdown, by Distribution Channel
    • 10.1.1.3.3 Japan: Asia Pacific Drug Delivery Systems Market Breakdown, by Application
  • 10.1.1.4 Australia: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Drug Delivery Systems Market Breakdown, by Route of Administration
    • 10.1.1.4.2 Australia: Asia Pacific Drug Delivery Systems Market Breakdown, by Distribution Channel
    • 10.1.1.4.3 Australia: Asia Pacific Drug Delivery Systems Market Breakdown, by Application
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Drug Delivery Systems Market Breakdown, by Route of Administration
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Drug Delivery Systems Market Breakdown, by Distribution Channel
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Drug Delivery Systems Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Drug Delivery Systems Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 BD
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 3M
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Novo Nordisk A/S
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BD
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Novo Nordisk A/S
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Boston Scientific Corporation
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Bausch Health Companies Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Baxter
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Boehringer Ingelheim
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Novartis AG
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 GlaxoSmithKline plc.
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Johnson & Johnson Services, Inc.
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - A Market

The List of Companies

 

  1. BD
  2. 3M
  3. Novo Nordisk A/S
  4. BD
  5. Novo Nordisk A/S
  6. Boston Scientific Corporation
  7. Bausch Health Companies Inc.
  8. Baxter
  9. Boehringer Ingelheim
  10. Novartis AG
  11. GlaxoSmithKline plc.
  12. Johnson & Johnson Services, Inc.

 

asia-pacific-drug-delivery-systems-market